New Diagnostic Tests Get Personal, PricewaterhouseCoopers LLP Reports

3/30/2010 9:13:55 AM

March 30 (Reuters) - Patients are finally starting to reap some of the benefits of personalized medicine as drug and diagnostic companies begin to use newly-acquired genetic information to develop so-called companion diagnostics -- tests used to tailor drugs to a patient's specific genetic makeup.

Read at Reuters

Read Article at

Related Companies

News Categories

• Reuters

• PricewaterhouseCoopers LLP

• Diagnostics

• Medical Dev. & Diag. - Product News

• Medical Dev. & Diag. - Industry